949459-68-1

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1024612-56-3 β³-L-homotyrosine methyl ester 
• 126825-16-9 N-tert-butyloxycarbonyl-(O-benzyl)-L-β-homotyrosine 
• 127106-65-4 4-(4-benzyloxy-phenyl)-3-tert-butoxycarbonylamino-butyric acid methyl ester 

Downstream Products

• 1426302-56-8 (S)-methyl 3-((tert-butoxycarbonyl)amino)-4-(4-(3-hydroxypropoxy)phenyl)butanoate 
• 1426302-52-4 (S)-3-(4-(3-(6-(3-mercaptopropanamido)hexanamido)propoxy)benzamido)-4-(4-(3-((4-methoxypyridin-2-yl)amino)propoxy)phenyl)butanoic acid 
• 1426302-50-2 (S)-3-(4-isopropoxybenzamido)-4-(4-(3-((4-methoxypyridin-2-yl)amino)propoxy)phenyl)butanoic acid 
• 1426302-58-0 (S)-methyl 3-((tert-butoxycarbonyl)amino)-4-(4-(3-((4-methoxypyridin-2-yl)amino)propoxy)phenyl)butanoate 
• 1426302-57-9 ((S)-methyl 3-(tert-Butoxycarbonyl)amino)-4-(4-(3-oxopropoxy)phenyl)butanoate 

Relevant academic research and scientific papers

Synthesis and initial pharmacology of dual-targeting ligands for putative complexes of integrin αvβ3 and PAR2

Unpublished data from our labs led us to hypothesize that activated protein C (aPC) may initiate an anti-inflammatory signal in endothelial cells by modulating both the integrin αVβ3 and protease-activated receptor 2 (PAR2), which may exist in close proxi

Peptide backbone modifications on the C-terminal hexapeptide of neurotensin

To compare backbone-induced susceptibilities with affinity changes that are caused by side-chain modifications in the respective positions, structure activity relationship studies on a series of NT(8-13) analogues were performed providing valuable insight